Helius stories
New Zealand patients could see fewer supply disruptions as locally grown and made medicinal cannabis medicines reach the market for the first time.
Mary Alice Simon's appointment is intended to boost production, quality systems and New Zealand's first medicinal cannabis trials.
Employers may need to rewrite drug policies, though experts say existing health and safety rules already cover impairment at work.
Access to cheaper medicinal cannabis for thousands of patients is expected to grow as licence applications are now under way.
New Zealand's medicinal cannabis sector gains a major research boost as Dr James Polston joins Helius after leading R&D at Trulieve.
Thousands of patients could benefit sooner if officials finalise regulations, licences and quality standards for the new scheme within 12 months.
Auckland billboards fronted by eight patients and advocates aim to reduce stigma as New Zealand's medicinal cannabis laws take shape.
